5YoKoi H,Mukoyama M,Sugawara A,et al.Role of connective tissue growth factor in fibronection expression and tubulointers titial[J].Am physiol Renal phsiol,2002,282(5):933-942 被引量：1
二级参考文献10
1Aiano T, Wakisaka M, Yoshinari M, et al. Peroxisome proliferator activated receptor gamma (PPAR-γ) expresses in rat mesangial cells and PPAR-γ agonists mdulati its differntitation[J]. Biochim Biophys Acta, 2000, 1297: 148-154 被引量：1
2Martis L, Topley N, Holmes CJ. Conventional and newer peritoneal dialysis solutions. In: Owen WF, Pereira JG, Sayegh MH, eds. Dialysis and Transplantation: a companion to Brenner and Rector's The Kidney[M]. Philadelphia: W.B. Saunders, 2000:179-198 被引量：1
3NKF-K/DOQI.Clinical practice guidelines for peritoneal dialysis adequacy: Update 2000[J]. Am J Kidney Dis,2001,37(Suppl 1):68-71 被引量：1
4Blom IE, Goldschmeding R, Leask A. Gene regulation of Connective tissue growth factor: new targets for antifibrotic therapy?[J].Matrix Biol, 2002, 21(6):473-482 被引量：1
5Ma LJ, Murcantoni C, Linton MF, et al. Peroxisome proliferator-activated receptor gamma agonist troglitazone protects against nondiabetic glomeralosclerosis in rat[J]. Kidney Int, 2001, 59: 1899-1910 被引量：1
6Henderson LW. Future developments in the treatment of end-stage renal disease: A North American perspective[J]. Am J Kidney Dis, 2000,35 (suppl 1):106-116 被引量：1
8Yokoi H, Mukoyama M, Sugawara A,et al. Role of connective tissue growth factor in fibronection expression and tubulointers titial fibrosis[J]. Am Physiol Renal Phsiol,2002,282(5):933-942 被引量：1
9Ihn H.Pathogenesis of fibrosis:role of TGFβ and CTGF[J].Curr Opin Pheumatol,2002,14(6):681-685. 被引量：1
